Greenwich, CTCIK 18425454 filings on record
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeLargest positions by weight
30 positions · Q4 2025
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Argenx Se | 62.7K | $52.75M | 11.6% | −14.7K | Reduced |
| 2 | Icon PLC | 247.1K | $45.02M | 9.9% | +64.5K | Added |
| 3 | Natera Inc | 183.3K | $41.98M | 9.2% | −20.4K | Reduced |
| 4 | Insmed Inc |
| 210.9K |
| $36.71M |
| 8.1% |
| −60.7K |
| Reduced |
| 5 | Illumina Inc | 231.2K | $30.32M | 6.7% | −91.1K | Reduced |
| 6 | Guardant Health Inc | 284.1K | $29.02M | 6.4% | 0 | Held |
| 7 | Neurocrine Biosciences Inc | 162.8K | $23.09M | 5.1% | 0 | Held |
| 8 | Biomarin Pharmaceutical Inc | 366.8K | $21.80M | 4.8% | 0 | Held |
| 9 | Fortrea Hldgs Inc | 1.22M | $21.02M | 4.6% | +229.8K | Added |
| 10 | Bridgebio Pharma Inc | 259.3K | $19.83M | 4.4% | 0 | Held |
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio